Cargando…

B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus

B cells and B-cell/T-cell collaborations are instrumental in the pathophysiology of systemic lupus erythematosus (SLE). This commentary highlights in particular the newly discovered role of B-cell-activating factor (BAFF; also known as TALL-1, THANK, BlyS, and zTNF4) as a positive regulator of B-cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dörner, Thomas, Putterman, Chaim
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128894/ https://www.ncbi.nlm.nih.gov/pubmed/11438034 http://dx.doi.org/10.1186/ar299

Ejemplares similares

TACI and BAFF-R mediate isotype switching in B cells
por: Castigli, Emanuela, et al.
Publicado: (2005)

Systemic Lupus Erythematosus
por: Putterman, Chaim, et al.
Publicado: (2012)

BAFF polymorphisms and serum levels of BAFF in Tunisian systemic lupus erythematosus patients
por: Laamiri, Nacira, et al.
Publicado: (2012)

The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells
por: Saulep-Easton, Damien, et al.
Publicado: (2015)

CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic biomarkers
por: Mizutani, Hironori, et al.
Publicado: (2018)

The MRL/lpr Mouse Strain as a Model for Neuropsychiatric Systemic Lupus Erythematosus
por: Gulinello, Maria, et al.
Publicado: (2011)

Expression of BAFF and BR3 in patients with systemic lupus erythematosus
por: Duan, J.H., et al.
Publicado: (2016)

No Evidence That Soluble TACI Induces Signalling via Membrane-Expressed BAFF and APRIL in Myeloid Cells
por: Nys, Josquin, et al.
Publicado: (2013)

CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism
por: Nelke, Johannes, et al.
Publicado: (2020)

The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus
por: Moore, Erica, et al.
Publicado: (2020)

The TNFSF Members APRIL and BAFF and Their Receptors TACI, BCMA, and BAFFR in Oncology, With a Special Focus in Breast Cancer
por: Kampa, Marilena, et al.
Publicado: (2020)

B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus
por: Wen, Jing, et al.
Publicado: (2016)

Metabolic Disturbances Associated with Systemic Lupus Erythematosus
por: Wu, Tianfu, et al.
Publicado: (2012)

Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus
por: Ameratunga, Rohan, et al.
Publicado: (2017)

Remodeling of Neurotransmission, Chemokine, and PI3K-AKT Signaling Genomic Fabrics in Neuropsychiatric Systemic Lupus Erythematosus
por: Iacobas, Dumitru, et al.
Publicado: (2021)

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice
por: Stock, Ariel D., et al.
Publicado: (2015)

BAFF system expression in double negative 2, activated naïve and activated memory B cells in systemic lupus erythematosus
por: Álvarez Gómez, Jhonatan Antonio, et al.
Publicado: (2023)

A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells
por: Haselmayer, Philipp, et al.
Publicado: (2017)

Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms
por: George-Chandy, Annie, et al.
Publicado: (2008)

BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus
por: Shin, Woori, et al.
Publicado: (2018)

Smoking associates with increased BAFF and decreased interferon-γ levels in patients with systemic lupus erythematosus
por: Raymond, Warren David, et al.
Publicado: (2021)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
por: Schwartzman-Morris, Julie, et al.
Publicado: (2012)

Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling
por: Mike, Elise V., et al.
Publicado: (2018)

April and Baff Connect Autoimmunity and Cancer
por: Ware, Carl F.
Publicado: (2000)

Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
por: Vallerskog, Therese, et al.
Publicado: (2006)

Investigations of a Rabbit (Oryctolagus cuniculus) Model of Systemic Lupus Erythematosus (SLE), BAFF and Its Receptors
por: Yang, Jiahui, et al.
Publicado: (2009)

Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus
por: Ortiz-Aljaro, Pilar, et al.
Publicado: (2022)

Elucidating the role of TNF-like weak inducer of apoptosis in the pathogenesis of cutaneous lupus
por: Doerner, Jessica, et al.
Publicado: (2014)

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus
por: Ramsey‐Goldman, Rosalind, et al.
Publicado: (2019)

Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
por: Marín-Rosales, Miguel, et al.
Publicado: (2022)

Toll-like receptor signalling in B cells during systemic lupus erythematosus
por: Fillatreau, Simon, et al.
Publicado: (2020)

Analysis of B-cell subpopulations in systemic lupus erythematosus
por: Dorner, T, et al.
Publicado: (2003)

BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 Proteins Are Related to Human Glioma Tumor Grade: Immunohistochemistry and Public Microarray Data Meta-Analysis
por: Pelekanou, Vassiliki, et al.
Publicado: (2013)

Systemic lupus erythematosus and cardiovascular disease
por: Ruilope, Luis M., et al.
Publicado: (2020)

Targeting B cells in systemic lupus erythematosus: not just déjà vu all over again
por: Eisenberg, Robert
Publicado: (2006)

Anti-TNF-α Therapies in Systemic Lupus Erythematosus
por: Zhu, Lang-Jing, et al.
Publicado: (2010)

Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2020)

The current status of targeting BAFF/BLyS for autoimmune diseases
por: Ramanujam, Meera, et al.
Publicado: (2004)

SLE – Hematopoietic stem cell transplantation for systemic lupus erythematosus
por: Burt, Richard K, et al.
Publicado: (2003)

In-/off-label use of biologic therapy in systemic lupus erythematosus
por: Gatto, Mariele, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_io2o5fs45apac5tub11gdih1fc